SUNNYVALE, Calif.--(BUSINESS WIRE)--Amarantus BioSciences, Inc. (OTCBB:AMBS), a biotechnology company developing Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF), a first-in-class disease–modifying therapeutic protein, today announced that it has been selected to present at 120th National Investment Banking Association’s Conference in Las Vegas, NV at Caesar’s Palace on Thursday, December 1st at 10:10am Pacific.
